Antibiotikaanvändning
|
|
|
- Virginia Tyler
- 8 years ago
- Views:
Transcription
1 Antibiotikaanvändning Akademiska sjukhuset T o m juni 2014
2 Receptförskriven och rekvirerad antibiotika (J01 inkl rifampicin)* Akademiska sjukhuset juni 2014 Källa: ehälsomyndigheten DDD Rekvirerad Recept *exkl metenamin (Hiprex)
3 Rekvirerad och receptförskriven antibiotika, Akademiska sjukhuset 2013 Källa: ehälsomyndigheten Rekvirerat Recept kinoloner makrolider, linkosamider trimetoprim, trim-sulfa övr antibakt medel cefalosporiner oral antibiotika vid tarminf (A07AA) rifampicin karbapenemer metronidazol p.o. aminoglykosider monobaktamer tetracykliner penicilliner DDD
4 Antibiotikaförskrivning (J01* & rifampicin) via recept, Akademiska sjukhuset per verksamhetsområde. Källa: ehälsomyndigheten juli juni 2012 juli juni 2013 juli juni 2014 Urologi Hud & kön Onkologi Akutsjukvård Hematologi Lung & allergi Plastikkirurgi Handkirurgi Njurmedicin Transplantationskirurgi Ögonsjukdomar Internmedcin Käkkirurgi Reumatologi Gastro-enterologi Kardiologi Neurokir/rehab/neurofys Endokrinologi och diabetes Neurologi Geriatrik Uppsala Smärtcentrum BUP Thoraxkirurgi och anestesi *exkl metenamin (Hiprex) Obstetrik och gynekologi Ortopedi ÖNH Kirurgi Infektionssjukdomar Barnsjukvården Recept
5 Rekvirerad och receptförskriven antibiotika (J01* & rifampicin) per verksamhetsområde/klinik på Akademiska sjukhuset juli juni Källa: ehälsomyndigheten Rekvirerat Receptförskrivet Kirurgi Barnsjukvård** Hud o kön ÖNH Hematolog Obstetrik & gyn Urologi Specialmedicin Onkoloig Lung- & allergi Geriatrik Akutsjukvård Ögonsjukd Neurokir Internmedicin Thoraxkir & anestesi Plastikkir Kardiologi & PCI Reumatologi Handkir Transplantationskir Anestesi & intensiv Käkkir Neurologi BUP Smärtcentrum *exkl metenamin (Hiprex) **barnkirurgi, barnonkologi & pediatrik Ortopedi Infektionssjd DDD
6 Följande bilder visar enbart rekvirerad antibiotika använd på Akademiska sjukhuset, dvs ej det som förskrivits via recept
7 Antibiotikaanvändning (J01*+rifampicin) på Akademiska sjukhuset i DDD samt DDD/100 vårddagar, juni 2014, per halvår. Källa: ehälsomyndigheten och ProDiver DDD DDD DDD/100 vårddagar DDD/100 vårddagar *exkl metenamin (Hiprex)
8 Antibiotikaanvändning (J01* & rifampicin), Akademiska sjukhuset per verksamhetsområde. Källa: ehälsomyndigheten juli juni 2012 juli juni 2013 juli juni 2014 BARNKIRURGI NEUROLOGI PEDIATRIK BARNONKOLOGI REHABILITERINGSMEDICIN ÖGONSJUKDOMAR *exkl metenamin (Hiprex) PLASTIKKIRURGI HEMATOLOGI THORAX KIRURGI OCH ANESTESI ONKOLOGI INTERNMEDICIN ÖNH LUNG OCH ALLERGISJUKDOMAR ANESTESI OCH INTENSIVVÅRD UROLOGI KARDIOLOGI OCH PCI SPECIALMEDICIN AKUTSJUKVÅRD GYNEKOLOGI OBSTETRIK NEUROKIRURGI GERIATRIK HUD, KÖNS & REUMA ORTOPEDI KIRURGI INFEKTIONSSJUKDOMAR DDD/år
9 Antibiotikaanvändning, Akademiska sjukhuset, DDD/halvår, 2011 juni Källa: ehälsomyndigheten
10 Användning av bensyl-pc, pip-tazo, karbapenemer, kinoloner och cefalosporiner, Akademiska sjukhuset 2009 juni 2014, DDD/halvår. Källa: ehälsomyndigheten
11 Användning av penicilliner (J01C), Akademiska sjukhuset 2011 juni 2014, DDD per halvår. Källa: ehälsomyndigheten
12 Användning av cefalosporiner (J01DB DE), Akademiska sjukhuset 2011 juni 2014, DDD per halvår. Källa: ehälsomyndigheten
13 Användning av kinoloner (J01MA), Akademiska sjukhuset 2011 juni 2014, DDD per halvår. Källa: ehälsomyndigheten
14 Neurologi Gyn Rehabmed Kinolonanvändning (J01 MA) per verksamhetsområde, Akademiska sjukhuset juli juni 2014 Källa: ehälsomyndigheten juli juni 2012 juli juni 2013 juli juni 2014 Infektion Ortopedi Internmedicin Specialmedicin Lung & allergi Akutsjukvård Neurokir ÖNH Kardiologi o PCI Thoraxkir & anestesi Plastikkir Anestesi & intensiv Hud, kön & reuma Klin immunologi & transfusionsmed Urologi Geriatrik Onkologi Hematologi Kirurgi DDD
15 Användning av karbapenemer (J01DH), Akademiska sjukhuset 2011 juni 2014, DDD per halvår. Källa: ehälsomyndigheten
16 Användning av aminoglykosider (J01GB), Akademiska sjukhuset 2011 juni 2014, DDD per halvår. Källa: ehälsomyndigheten
17 Användning av övriga antibakteriella medel (J01X), Akademiska sjukhuset, 2011 juni 2014, DDD per halvår. Källa: ehälsomyndigheten
18 Vankomycinanvändning på Akademiska sjukhuset juni 2014, parenteralt, kapslar givna på sjukhuset samt receptförskrivna kapslar Källa: ehälsomyndigheten DDD parenteralt oralt givet på sjukhuset kapslar på recept
19 DDD angivet i gram Källa: WHOCC, Oslo, DDD-index Substans oralt parenteralt amikacin 1 amoxicillin 1 1 amoxicillin och enzymhämmare 1 amoxi 3 amoxi ampicillin 2 2 azitromycin 0,3 0,5 aztreonam inh. 0,225 4 bensatin bensylpenicillin 3,6 bensylpenicillin (pc G) 3,6 cefadroxil 2 cefalexin 2 cefalotin 4 cefepim 2 cefixim 0,4 cefotaxim 4 cefpodoxim 0,4 ceftazidim 4 ceftibuten 0,4 ceftriaxon 2 cefuroxim 0,5 3 ciprofloxacin 1 0,5 daptomycin 0,28 dikloxacillin 2 2 doxycyklin 0,1 0,1 ertapenem 1 erytromycin 1 fenoximetylpenicillin (pc V) 2 flukloxacillin 2 2 fosfomycin 3 8 fusidinsyra 1,5 1,5 gentamicin 0,24 imipenem med enzymhämmare 2 imip. klaritromycin 0,5 1 klindamycin 1,2 1,8 Substans oralt parenteralt kloramfenikol 3 3 kloxacillin 2 2 kolistin inh.lösn. 3 ME 3 ME levofloxacin 0,5 0,5 linezolid 1,2 1,2 lorakarbef 0,6 lymecyklin 0,6 0,6 mecillinam 1,2 meropenem 2 metronidazol 1,5 moxifloxacin 0,4 0,4 netilmicin 0,35 0,35 nitrofurantoin 0,2 norfloxacin 0,8 ofloxacin 0,4 0,4 oxitetracyklin 1 1 piperacillin 14 piperacillin och enzymhämmare pivmecillinam 0,6 14 piperac. polymyxin b 0,15 rifampicin 0,6 0,6 roxitromycin 0,3 spektinomycin 3 spiramycin 3 sulfadiazin 0,6 sulfametoxazol och trimetoprim teikoplanin 0,4 telitromycin 0,8 tetracyklin 1 1 tigecyklin 0,1 tobramycin inh.lösn. 0,3, inh.pulv. 0,112 0,24 trimetoprim 0,4 0,4 vankomycin 2 2
Liofilchem - Antibiotic Disk Interpretative Criteria and Quality Control - F14013 - Rev.7 / 20.02.2013
Liofilchem Antibiotic Disk Interpretative Criteria and Quality Control F0 Rev.7 /.02. Amikacin AK Amoxicillin + Clavulanic acid AUG (+) ATCC 352 Coagulasenegative staphylococci Amoxicillin + Clavulanic
Date: November 30, 2010
Department of Health and Human Services Public Health Service Food and Drug Administration Center for Drug Evaluation and Research Date: November 30, 2010 To: Through: From: Subject: Drug Name(s): Application
Drug Use Review. Edward Cox, M.D. Director Office of Antimicrobial Products
Department of Health and Human Services Public Health Service Food and Drug Administration Center for Drug Evaluation and Research Drug Use Review Date: April 5, 2012 To: Through: Edward Cox, M.D. Director
ANTIMICROBIAL AGENT CLASSES AND SUBCLASSES
ANTIMICROBIAL AGENT CLASSES AND SUBCLASSES FOR USE WITH CLSI DOCUMENTS M2 AND M7 Beta-lactams: penicillins e penicillin a penicillin beta-lactam/beta-lactamase inhibitor combinations aminopenicillin a
Product Catalogue 2015 Clinical and Industrial Microbiology
Product Catalogue 201 Antibiotic discs in cartridge µg CLSI 1,2 EUCAST 3,4 BSAC Packaging * Amikacin AK x0 Discs 9004 Amoxicillin AML 2 x0 Discs 911 Amoxicillin AML x0 Discs 9133 Amoxicillin AML 2 x0 Discs
British Society for Antimicrobial Chemotherapy
British Society for Antimicrobial Chemotherapy BSAC to actively support the EUCAST Disc Diffusion Method for Antimicrobial Susceptibility Testing in preference to the current BSAC Disc Diffusion Method
Dosing information in renal impairment
No. Drug name Usual dose Adjustment for Renal failure estimated CrCl (ml/min) Aminoglycoside antibiotics 1 Amikacin 2 Gentamicin 7.5 mg /kg q 12 hr > 50-90 7.5 mg/kg q 12 hr 10-50 7.5 mg/kg q 24 hr < 10
Determination of minimum inhibitory concentrations. Jennifer M. Andrews* Department of Microbiology, City Hospital NHS Trust, Birmingham B18 7QH, UK
Journal of Antimicrobial Chemotherapy (2001) 48, Suppl. S1, 5 16 Determination of minimum inhibitory concentrations JAC Jennifer M. Andrews* Department of Microbiology, City Hospital NHS Trust, Birmingham
HUSRES Annual Report 2015
HUSRES Annual Report 2015 1 This report is based on the HUSLAB/Whonet database 2015, which contains data on more than 190.000 microbes. EUCAST 2015 clinical breakpoints have mainly been used. The doses
for Extended Stability Parenteral Drugs Third Edition Caryn M. Bing, R.Ph., M.S., FASHP Editor
Extended Stability for Parenteral Drugs Third Edition Editor Caryn M. Bing, R.Ph., M.S., FASHP 1 American Society of Health-System Pharmacists Bethesda, Maryland Contents Preface Acknowledgments x/ Dedication
HUSRES Annual Report 2008 Martti Vaara. www.huslab.fi www.intra.hus.fi
HUSRES Annual Report 2008 Martti Vaara www.huslab.fi www.intra.hus.fi The basis of this HUSRES 2008 report is the HUSLAB/Whonet database 2008, which contains susceptibility data on about 180.000 bacteria
Urinary Tract Infections
Urinary Tract Infections Overview A urine culture must ALWAYS be interpreted in the context of the urinalysis and patient symptoms. If a patient has no signs of infection on urinalysis, no symptoms of
Helsingin ja Uudenmaan alueen herkkyystilastoja 2003. www.infektiofoorumi.fi www.huslab.fi www.intra.hus.fi
Helsingin ja Uudenmaan alueen herkkyystilastoja 2003 www.infektiofoorumi.fi www.huslab.fi www.intra.hus.fi 12 10 Staph. aureus Pus and blood isolates % R+I, at HUCH (7 hospitals) [one isolate/patient (the
How To Treat Mrsa From A Dead Body
HUSRES Annual Report 2012 Martti Vaara www.huslab.fi www.intra.hus.fi Martti Vaara 2013 1 The basis of this HUSRES 2012 report is the HUSLAB/Whonet database 2012, which contains susceptibility data on
ANTIBIOTICS IN SEPSIS
ANTIBIOTICS IN SEPSIS Jennifer Curello, PharmD, BCPS Clinical Pharmacist, Infectious Diseases Antimicrobial Stewardship Program Ronald Reagan UCLA Medical Center October 27, 2014 The power of antibiotics
HUSRES Annual Report 2010 Martti Vaara www.huslab.fi www.intra.hus.fi
HUSRES Annual Report 2010 Martti Vaara www.huslab.fi www.intra.hus.fi Martti Vaara, 2/2011 1 The basis of this HUSRES 2010 report is the HUSLAB/Whonet database 2010, which contains susceptibility data
Received 4 July 2010; returned 10 August 2010; revised 27 September 2010; accepted 30 September 2010
J Antimicrob Chemother 2011; 66: 205 209 doi:10.1093/jac/dkq404 Advance Access publication 8 November 2010 Sustained reduction in antimicrobial use and decrease in methicillin-resistant Staphylococcus
How To Treat Mrsa In Finnish
HUSRES Annual Report 2013 Martti Vaara www.huslab.fi www.intra.hus.fi Martti Vaara 2014 1 The basis of this HUSRES 2013 report is the HUSLAB/Whonet database 2013, which contains susceptibility data on
NEW SCHEDULE H1 INSERTED IN DRUGS AND COSMETICS RULES :
LOCOST 85, GIDC Estate, Por-Ramangamdi, N.H.8, Dist. Vadodara - 391 243 Gujarat, India. Tel. No.: (91-265) 2830009 Fax No.: (P.P.) 2831446 E-mail: locost@sify.com Website: www.locostindia.com A Public
Profylax med antibiotika. mot infektion i kirurgin. Per-Olof Nyström Gastrocentrum kirurgi Karolinska
Profylax med antibiotika mot infektion i kirurgin Per-Olof Nyström Gastrocentrum kirurgi Karolinska Antibiotikaförsäljning, slutenvård i Sverige under perioden 2001-2007. Sverige Stockholm DDD per 1000
Version 11.1 May 2012
BSAC Methods for Antimicrobial Susceptibility Testing Version 11.1 May 2012 All enquiries to: Jenny Andrews at: + 44 (0) 121 507 5693 Email: jenny.andrews1@nhs.net Contents Page Working Party members 5
Challenges and possible changes in Norwegian curriculums 2009-2015 Perspectives from Bergen
Challenges and possible changes in Norwegian curriculums 2009-2015 Perspectives from Bergen Kjell Haug Prodekanus Det medisinsk-odontologiske fakultet Universitetet i Bergen Medicine 2005 A new curriculum
Treatment of Fever and Infection in Children with Transfusion Dependent Thalassaemia
Treatment of Fever and Infection in Children with Transfusion Dependent Thalassaemia Document Information Version: 2 Date: June 2014 Authors (incl. job title): Professor David Rees, Sue Height (consultant
Helsingin ja Uudenmaan alueen herkkyystilastoja 2004. www.huslab.fi www.intra.hus.fi
Helsingin ja Uudenmaan alueen herkkyystilastoja 2004 www.huslab.fi www.intra.hus.fi Staph. aureus 2004 (%R+I) Pus and blood isolates at six hospitals (M,T,L,K,N,Ma) in Helsinki University Central Hospital,
ORIGINAL ARTICLE. 10.1111/j.1469-0691.2006.01613.x
ORIGINAL ARTICLE 10.1111/j.1469-0691.2006.01613.x Benchmarking antimicrobial drug use at university hospitals in five European countries V. Vlahović-Palc evski 1, U. Dumpis 2, P. Mitt 3, J. Gulbinovic
Received 22 March 2006/Returned for modification 2 May 2006/Accepted 14 September 2006
JOURNAL OF CLINICAL MICROBIOLOGY, Nov. 2006, p. 4085 4094 Vol. 44, No. 11 0095-1137/06/$08.00 0 doi:10.1128/jcm.00614-06 Copyright 2006, American Society for Microbiology. All Rights Reserved. Two-Center
Practice Guidelines. Updated Guideline on Diagnosis and Treatment of Intra-abdominal Infections
Updated Guideline on Diagnosis and Treatment of Intra-abdominal Infections CARRIE ARMSTRONG Guideline source: Surgical Infection Society, Infectious Diseases Society of America Literature search described?
FORMULARY. (List of Covered Drugs) Molina Dual Options Medicare-Medicaid Plan
FORMULARY (List of Covered Drugs) 2015 Molina Dual Options Medicare-Medicaid Plan Version 14 UPDATED: 11/2015 Member Services (877) 901-8181, TTY/TDD 711 Monday - Friday, 8 a.m. - 8 p.m. local time H8046_15_16003_0002_MMPILRx
SWEDRES2004 A Report on Swedish Antibiotic Utilisation and Resistance in Human Medicine
SWEDRES A Report on Swedish Antibiotic Utilisation and Resistance in Human Medicine STRAMA The Swedish Strategic Programme for the Rational Use of Antimicrobial Agents 1.1 Preface...3 1.2 Contributors...3
Version 12 May 2013. BSAC Methods for Antimicrobial Susceptibility Testing. All enquiries to: Mandy Wootton. Email: Mandy.Wootton@wales.nhs.
BSAC Methods for Antimicrobial Susceptibility Testing Version 12 May 2013 All enquiries to: Mandy Wootton Email: Mandy.Wootton@wales.nhs.uk Telephone: +44 (0) 2920 746581 Contents Page Working Party members
Streptococcus pneumoniae IgG AB (13 Serotypes), MAID... 7
Volume 12 December 2011 Table of Contents Summary of Test Changes... 3 Test Changes... 6 Human Anti-Mouse AB (HAMA), ELISA... 6 Hepatitis E Antibody (IgG, IgM)... 6 Hepatitis E Antibody (IgG)... 6 Hepatitis
INTRAVENOUS DRUG QUICKGUIDE
INTRAVENOUS DRUG QUICKGUIDE GENERAL NOTES IMPORTANT THIS GUIDE IS AN AIDE MEMOIRE ONLY, AND SHOULD NOT REPLACE YOUR PROFESSIONAL REQUIREMENT TO USE MANUFACTUER S LICENSED INFORMATION TO INFORM YOUR PREPARATION
2016 PQRS OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY
Measure #65 (NQF 0069): Appropriate Treatment for Children with Upper Respiratory Infection (URI) National Quality Strategy Domain: Efficiency and Cost Reduction 2016 PQRS OPTIONS FOR INDIVIDUAL MEASURES:
Appropriate Treatment for Children with Upper Respiratory Infection
BCBS ACO Measure Appropriate Treatment for Children with Upper Respiratory Infection HEDIS Measure CPT II coding required: YES Click here to go to Table of Contents BCBS Measure: Page 50 of 234 Dated:
Intra-abdominal abdominal Infections
Intra-abdominal abdominal Infections Marnie Peterson, Pharm.D., BCPS Dept. of Pediatric Infectious Diseases Medical School University of Minnesota Intra-abdominal abdominal Infections Intra-abdominal abdominal
Cluster of urinary tract infections due to XDR Pseudomonas aeruginosa. Dr Marie Hallin Service de Microbiologie Hôpital Erasme
Dr Marie Hallin Service de Microbiologie Hôpital Erasme ULB-Hôpital Erasme: 800 beds Nephrology/Renal transplantation 3300 urines/month 15/05/10-2 Urines 13/05/10: BG100504717 (M) 1946 ER WBC: 123/µL RBC:
AETNA BETTER HEALTH OF OHIO a MyCare Ohio plan
AETNA BETTER HEALTH OF OHIO a MyCare Ohio plan 2015 List of Covered Drugs/Formulary Aetna Better Health of Ohio, a MyCare Ohio plan (Medicare-Medicaid Plan) is a health plan that contracts with Medicare
Urinary Tract Infection and Asymptomatic Bacteriuria Guidance
Urinary Tract Infection and Asymptomatic Bacteriuria Guidance Urinary tract infection (UTI) is the most common indication for antimicrobial use in hospitals and a significant proportion of this use is
PRMCE ANTI-INFECTIVES SELECTION GUIDELINE FOR ADULTS
PRMCE ANTI-INFECTIVES SELECTION GUIDELINE FOR ADULTS SKIN AND SOFT TISSUE INFECTIONS: Mild A. Cellulitis: MRSA uncommonly causes cellulitis in the absence of a wound abscess. Add empiric anti-mrsa therapy
Oscar E. Guzman, PharmD, BCPS
P Chapter 32 Antibiotic Streamlining Oscar E. Guzman, PharmD, BCPS Introduction Antibiotic streamlining is one of the most important methods pharmacists can use to encourage appropriate antibiotic use,
PROJECT LIST GENERIC PRODUCTS
PROJECT LIST GENERIC PRODUCTS Acetylcysteine, Effervescent tablets 200 mg, 600 mg Alendronate sodium, Tablets 10, 70 mg Alfuzosin,Tablets 2.5mg Alfuzosin, ER Tablets 10 mg Ambroxol, Effervescent tablets
MARAN 2015. NethMap 2015. Consumption of antimicrobial agents and antimicrobial resistance among medically important bacteria in the Netherlands
NethMap 215 Consumption of antimicrobial agents and antimicrobial resistance among medically important bacteria in the Netherlands MARAN 215 Monitoring of Antimicrobial Resistance and Antibiotic Usage
Andreas Heddini, MD, PhD. ReAct Action on Antibiotic Resistance
Andreas Heddini, MD, PhD ReAct Action on Antibiotic Resistance Patients with pneumonia and bacteria in blood Penicillin Penicillin increased the chance of survival from 10% to 90% % surviing Days Untreated
Urinary tract infections caused by extended spectrum β-lactamase (ESBL) producing Escherichia coli and Klebsiella pneumoniae
African Journal of Biotechnology Vol. 10(73), pp. 16661-16666, 21 November, 2011 Available online at http://www.academicjournals.org/ajb DOI: 10.5897/AJB11.2449 ISSN 1684 5315 2011 Academic Journals Full
2015 Formulary (List of Covered Drugs)
Blue Cross Medicare Advantage Basic (HMO) SM Blue Cross Medicare Advantage Premier Plus (HMO-POS) SM 015 Formulary (List of Covered Drugs) PLEASE READ: THIS DOCUMENT CONTAINS INFORMATION ABOUT THE DRUGS
How To Get A Drug Plan To Pay For A Prescription From Acpa
+B/LVW2I'UXJV5B$SSURYHG 2015 List of Covered s (Formulary) FOR MORE INFORMATION, contact Member Services at 1-855-735-4398 from 8 a.m. to 8 p.m., seven days a week. TTY users call 711. On weekends and
Therapeutic protocoles for adults concerning ESBL Enterobacteria infections in health care institutions
Therapeutic protocoles for adults concerning ESBL Enterobacteria infections in health care institutions CYSTITIS The growing importance of resistance to quinolones, their environmental impact and reduced
OXOiD KÜLTÜR BESİYERLERİ
AG 020 C OXOID PLASTIC POUCHES for ANAEROGEN & CAMPYGEN 1 x 20 Adet AG 025 A OXOID ANAEROJAR 2.5lt. 1 Adet AG 029 A OXOID ANAEROJAR PLATE CARRIER 1 Adet AN 005 C OXOID SEALING CLIPS for PLASTIC POUCHES
Appendix M: Guidelines for the Prophylaxis and Management of Intraabdominal, Biliary, and Appendiceal Infections
Appendix M: Guidelines for the Prophylaxis and Management of Intraabdominal, Biliary, and Appendiceal Infections University of Wisconsin Hospital and Clinics Intraabdominal Infections Prophylaxis and Management
CAP, HAP, VAP, & HCAP
Objectives Following the presentation, the participant will be able to: CP, HP, VP, & HCP John C. Rotschafer, Pharm. D. Professor College of Pharmacy University of Minnesota 1. Identify typical, atypical,
growing problem By: Jena Cummins, Doctor of Pharmacy Candidate
Clostridium difficile: A growing problem By: Jena Cummins, Doctor of Pharmacy Candidate Introduction The word difficile il is Latin for the word difficult. Clostridium difficile, affectionately known as
EMERGENCY MEDICINE IN DISASTER PLANNING
EMEGENCY MEDICINE IN DISASTE PLANNING PASET VASINANUKON M.D. DEPATEMENT OF EMEGENCY MEDICINE PINCE OF SONGKLANAKAIND UNIVESITY HOSPITAL HATYAI, SONGKLA, THAILAND WHAT IS DISASTE : MASSIVE DESTUCTION OUT
Prescription Drug Guide
2012 Prescription Drug Guide Humana Group Medicare Formulary List of covered drugs Humana Group Medicare Plus 3 PLEASE READ: THIS DOCUMENT CONTAINS INFORMATION ABOUT THE DRUGS WE COVER IN THIS PLAN. Y0040_PDG12b_Final_522C
CODE NO. PRODUCT NAME METHODOLOGY PACK SIZE HEPATITIS C
CODE NO. PRODUCT NAME METHODOLOGY PACK SIZE HEPATITIS C 53FT200-10 Signal HCV Ver. 2.0 Flow Through 10 Tests 53FT200-50 Signal HCV Ver. 2.0 Flow Through 50 Tests 53EL100-96 Innova ELISA 96 Wells HEPATITIS
Gram negatif bakterilerde GSBL üretiminin üç farklı yöntemle araştırılması ve antibiyotik direnç oranları ÖZET
Araştırma Makalesi/Original Article Makale Dili İngilizce /Article Language English Türk Hijyen ve Deneysel Biyoloji Dergisi Investigation of three different methods for detection of ESBL production and
IDSA GUIDELINES EXECUTIVE SUMMARY
IDSA GUIDELINES Diagnosis and Management of Complicated Intra-abdominal Infection in Adults and Children: Guidelines by the Surgical Infection Society and the Infectious Diseases Society of America Joseph
Drug Utilization and Evaluation of Cephalosporin s At Tertiary Care Teaching Hospital, Bangalore
Research Article Drug Utilization and Evaluation of Cephalosporin s At Tertiary Care Teaching Hospital, Bangalore HS. Shekar 1*, HR. Chandrashekhar 2, M. Govindaraju 3, P. Venugopalreddy 1, Chikkalingiah
NewYork-Presbyterian Hospital Sites: Columbia University Medical Center Guideline: Medication Use Manual Page 1 of 12
Page 1 of 12 TITLE: ANTIBIOTICS IN ADULT PATIENTS EMPIRIC USE GUIDELINES, COLUMBIA UNIVERSITY MEDICAL CENTER MEDICATION GUIDELINE PURPOSE: These are the 2011 guidelines for the empiric use of antibiotics
Beta-Lactamase Encoding Gene Among Extended Spectrum B-Lactamase Positive Wound Isolates of Pseudomonas
Arch Pediatr Infect Dis. 2015 October; 3(4): e26362. Published online 2015 October 12. doi: 10.5812/pedinfect.26362 Research Article Molecular Detection of bla VEB-1 Beta-Lactamase Encoding Gene Among
BD Sensi-Disc Susceptibility Test Discs
INSTRUCTIONS FOR USE BD SENSI-DISCS SD-BD.01 Rev.: May 2005 BD Sensi-Disc Susceptibility Test Discs INTENDED USE Sensi-Disc susceptibility test discs are used for semi-quantitative in vitro susceptibility
July 2015 P & T Updates
Commercial Triple Tier 4th Tier Applicable Traditional CORLANOR 3 2 2 tablets per day GLYXAMBI 3 2 1 tablet per day Alternatives carvedilol, bisoprolol, metoprolol succinate, digoxin, hydralazine, isosorbide
SEA-HLM-415 Distribution: General. Establishment of national laboratory-based surveillance of antimicrobial resistance
SEA-HLM-415 Distribution: General Establishment of national laboratory-based surveillance of antimicrobial resistance World Health Organization 2011 All rights reserved. Requests for publications, or for
Clinical Practice Guidelines for Antimicrobial Prophylaxis in Surgery
600 ASHP Therapeutic Guidelines Clinical Practice Guidelines for Antimicrobial Prophylaxis in Surgery These guidelines were developed jointly by the American Society of Health-System Pharmacists (ASHP),
IDSA GUIDELINES EXECUTIVE SUMMARY
IDSA GUIDELINES International Clinical Practice Guidelines for the Treatment of Acute Uncomplicated Cystitis and Pyelonephritis in Women: A 2010 Update by the Infectious Diseases Society of America and
Kalpana Gupta, M.D. Associate Professor Department of Medicine Section of Infectious Diseases Boston University School of Medicine
2010 Clinical Practice Guidelines by the Infectious Diseases Society of America and the European Society for Clinical Microbiology and Infectious Diseases Kalpana Gupta, M.D. Associate Professor Department
English Surveillance Programme for Antimicrobial Utilisation and Resistance (ESPAUR): Validation protocol for NHS Acute Trust Antimicrobial
English Surveillance Programme for Antimicrobial Utilisation and Resistance (ESPAUR): Validation protocol for NHS Acute Antimicrobial Consumption Data About Public Health England Public Health England
Escherichia coli Harboring mcr-1 and bla CTX-M on a Novel IncF Plasmid: First report of. mcr-1 in the USA
AAC Accepted Manuscript Posted Online 26 May 2016 Antimicrob. Agents Chemother. doi:10.1128/aac.01103-16 Copyright 2016 McGann et al. This is an open-access article distributed under the terms of the Creative
Antimicrobial Therapy. Otolaryngology Head and Neck Surgery
Pocket Guide to Antimicrobial Therapy in Otolaryngology Head and Neck Surgery 13th Edition DAVID N.F. FAIRBANKS, M.D. The American Academy of Otolaryngology Head and Neck Surgery Foundation EMPIRIC DRUG
May 2015 P&T Updates. Prior Authorization. Traditional. Formulary. Yes No. Formulary. Non Formulary. Non Formulary. Non Formulary
Commercial Triple Tier 4th Tier Applicable Traditional s EVOTAZ 2 2 Alternatives Flovent Diskus/HFA, Pulmicort Flexhaler, Qvar, Asmanex HFA eszopiclone, zaleplon, zolpidem, amitriptyline, mirtazapine,
Complicated urinary tract infections: practical solutions for the treatment of multiresistant Gram-negative bacteria
J Antimicrob Chemother 2010; 65 Suppl 3: iii25 33 doi:10.1093/jac/dkq298 Complicated urinary tract infections: practical solutions for the treatment of multiresistant Gram-negative bacteria Ann Pallett
Welcome. Quality. Ethical Statement. Website This Catalogue is available electronically from our website: www.mastgrp.com
IVD solutions through partnership Welcome Welcome to the Mast Group Ltd. Product Catalogue effective from January 1st, 2015. The catalogue comprises ordering information on Mast s extensive portfolio of
Diabetic foot infection diagnosis and treatment workshop
Diabetic foot infection diagnosis and treatment workshop Nashwan Al Naiemi Medical Microbiologist, ZGT, Almelo Edgar J.G. Peters Internist, VU Univ Med Cent, Amsterdam Subjects Introduction / case Diagnosis
MEDICAL COLLEGE & HOSPITAL IN DOOR ESSENTIAL DRUG LIST
ANNEXURE - D MEDICAL COLLEGE & HOSPITAL IN DOOR ESSENTIAL DRUG LIST Bihar EDL 1. Anaesthetics 1.1 Local Anaesthetics Bupivacaine Injection Plain-0.5% (5mg/ml) Hydrochloride Heavy-0.5% + 80mg/ml Dextrose
Vancomycin. Beta-lactams. Beta-lactams. Vancomycin (Glycopeptide) Rifamycins (rifampin) MID 4
Antibiotic Classes Introduction to Antimicrobials Rachel J. Gordon, MD, MPH Assistant Professor of Clinical Medicine and Epidemiology Beta-lactams Inhibit cell wall synthesis Penicillins Cephalosporins
Changes in the use of broad-spectrum antibiotics after cefepime shortage: a time
AAC Accepts, published online ahead of print on 28 November 2011 Antimicrob. Agents Chemother. doi:10.1128/aac.05560-11 Copyright 2011, American Society for Microbiology and/or the Listed Authors/Institutions.
How To Test For Carbapenemase
Available online at www.scholarsresearchlibrary.com Annals of Biological Research, 2012, 3 (12):5659-5664 (http://scholarsresearchlibrary.com/archive.html) ISSN 0976-1233 CODEN (USA): ABRNBW A study on
SCHEDULE No. 1: Oral solid dosage forms: Fluoroquinolones
ANNEX B/ SECTION 8: TECHNICAL SPECIFICATIONS NOTE: The estimated Global need for required below products is provided in Annex H of this ITB. Actual quantity to be ordered in 2015 can vary due to countries
Penetration of Antimicrobial Agents into the Prostate
Pharmacology Chemotherapy 2003;49:269 279 DOI: 10.1159/000074526 Received: December 23, 2002 Accepted after revision: March 18, 2003 Penetration of Antimicrobial Agents into the Prostate Konstantin Charalabopoulos
PLEASE READ: THIS DOCUMENT CONTAINS INFORMATION ABOUT THE DRUGS WE COVER IN THIS PLAN.
01 Blue BCN Advantage HMO BCN Advantage HMO-POS Medicare and more Care Network of Michigan is a nonprofit corporation and independent licensee of the Blue Cross and Blue Shield Association. BCN Advantage
Antimicrobial Activity and Spectrum of PPI-0903M (T-91825), a Novel Cephalosporin, Tested against a Worldwide Collection of Clinical Strains
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, Aug. 2005, p. 3501 3512 Vol. 49, No. 8 0066-4804/05/$08.00 0 doi:10.1128/aac.49.8.3501 3512.2005 Copyright 2005, American Society for Microbiology. All Rights Reserved.
Optimizing Antimicrobial Susceptibility Test Reporting
JOURNAL OF CLINICAL MICROBIOLOGY, Sept. 2011, p. S15 S19 0095-1137/11/$12.00 doi:10.1128/jcm.00712-11 Copyright 2011, American Society for Microbiology. All Rights Reserved. VOL. 49, NO. 9 SUPPL. Optimizing
Prevalence of Klebsiella pneumoniae Encoding Genes for Ctx-M-1, Tem-1 and Shv-1 Extended-Spectrum Beta Lactamases (ESBL) Enzymes in Clinical Specimens
Jundishapur J Microbiol. 2013 December; 6(10): e8256. Published online 2013 December 1. DOI: 10.5812/jjm.8256 Research Article Prevalence of Klebsiella pneumoniae Encoding Genes for Ctx-M-1, Tem-1 and
Anti Protozoal. Albendazole Oral Suspension USP Albendazole Tablets USP 400 mg Anti Malarial
ANTI-INFECTIVES Anti Biotics Levofloxacin Tablets 250, 500, 750 mg Ofloxacin Tablets 200, 400 mg Sparfloxacin Tablets 200 mg Ciprofloxacin Tablets USP 250, 500 mg Ofloxacin & Ornidazole Tablets Nitrofurantoin
Rapid antimicrobial susceptibility testing of clinical isolates by digital time-lapse microscopy
Eur J Clin Microbiol Infect Dis (2015) 34:2385 2394 DOI 10.1007/s10096-015-2492-9 ORIGINAL ARTICLE Rapid antimicrobial susceptibility testing of clinical isolates by digital time-lapse microscopy M. Fredborg
Practice Guidelines for the Management of Bacterial Meningitis
IDSA GUIDELINES Practice Guidelines for the Management of Bacterial Meningitis Allan R. Tunkel, 1 Barry J. Hartman, 2 Sheldon L. Kaplan, 3 Bruce A. Kaufman, 4 Karen L. Roos, 5 W. Michael Scheld, 6 and
ANTICANCER Carboplatin Injection BP 10 mg/ ml Injection 150 mg/15 ml vial 450 mg/45 ml vial
CATEGORY MOLECULE NAME PHARM SPECN STRENGTH DOSAGE FORM PACK SIZE TYPE OF FORMLN ANTICANCER Carboplatin BP 10 mg/ ml 150 mg/15 ml vial 450 mg/45 ml vial Cisplatin BP 1 mg/ ml 10 mg/ 10 ml vial, 50 mg/
Objectives. Fluids. Sterile IV Techniques. How many of you have sterile compounding technique procedures at your institution?
Objectives Intravenous Medications in the Intensive Care Unit Paul Juang, Pharm.D., BCPS Assistant Professor of Pharmacy Practice St. Louis College of Pharmacy April 16, 2011 The speaker has no conflict
Key words: antibiotics, antiseptics, resistance, burns, comlications, microorganisms.
Nazarchuk Oleksandr, Nahaichuk Vasyl, Paliy Viktor, Kovalenko Iryna. Microbiological aspects of the effectiveness of antimicrobial drugs. Journal of Education, Health and Sport. 2015;5(6):19-28. ISSN 2391-8306.
HPMS Approved Formulary File Submission ID: 00016311, Version Number 6.
UPMC for Life 2016 Formulary (List of Covered Drugs) PLEASE READ: THIS DOCUMENT CONTAINS INFORMATION ABOUT THE DRUGS WE COVER IN THIS PLAN. HPMS Approved Formulary File Submission ID: 00016311, Version
SURGICAL PROPHYLAXIS: ANTIBIOTIC RECOMMENDATIONS FOR ADULT PATIENTS
Page 1 of 8 TITLE: SURGICAL PROPHYLAXIS: ANTIBIOTIC RECOMMENDATIONS FOR ADULT PATIENTS GUIDELINE: Antibiotics are administered prior to surgical procedures to prevent surgical site infections. PURPOSE:
OXOID FİYAT LİSTESİ ÜRÜN AÇIKLAMASI
ANTİBİYOGRAM DİSKLERİ 1 CT 107 B OXOID AMIKACIN 30 μg AK 5x50 Disk 2 CT 061 B OXOID AMOXYCILLIN 25 μg AML 5x50 Disk 3 CT 060 B OXOID AMOXYCILLIN 2 μg AML 5x50 Disk 4 CT 161 B OXOID AMOXYCILLIN 10 μg AML
California Gonorrhea Treatment Guidelines
Califnia Gonrhea Treatment Guidelines These guidelines were developed by the Califnia Department of Public Health (CDPH) Sexually Transmitted Diseases (STD) Control Branch in conjunction with the Califnia
Skin and Soft Tissue Infections
Skin and Soft Tissue Infections Cellulitis Note: The most common etiology of cellulitis with purulent drainage is S. aureus, although Group A streptococci and other streptococcal species can also present
Adult Antimicrobial Guidelines 2011-2013. Cork University Hospital
Adult Antimicrobial Guidelines 2011-2013 Cork University Hospital your hands wash your hands wash your hands wash your hands wash your hands wash your hands wash your hands wash your hands wash your hands
2016 Cigna-HealthSpring Rx COMPREHENSIVE DRUG LIST (Formulary)
2016 Cigna-HealthSpring Rx COMPREHENSIVE LIST (Formulary) Please read: This document contains information about all of the drugs we cover in this plan. Plan covered Cigna-HealthSpring Rx Secure (PDP) This
ANTIMICROBIAL USE GUIDELINES
ANTIMICROBIAL USE GUIDELINES University of Wisconsin Hospital and Clinics Pharmacy and Therapeutics Committee Department of Pharmacy Drug Policy Program July 2011 to June 2012 Twenty-First Edition PREFACE
Culture and sensitivity pattern of micro-organism isolated from diabetic foot infections in a tertiary care hospital
Int J Cur Biomed Phar Res. 0; (): 0. Contents lists available at CurrentSciDirect Publications International Journal of Current Biomedical and Pharmaceutical Research CurrentSciDirect Publication Journal
Beta-lactam antibiotics - Cephalosporins
Beta-lactam antibiotics - Cephalosporins Targets - PBP s Activity - Cidal - growing organisms (like the penicillins) Principles of action - Affinity for PBP s Permeability ypropertiesp Stability to bacterial
Note. 2.0 Background. 1.0 Introduction RECOMMENDATION
Interim recommendations for the reporting of extensively drug resistant and pan-drug resistant isolates of Enterobacteriaceae, Pseudomonas aeruginosa, Acinetobacter spp. and Stenotrophomonas maltophilia